Modelling Parkinson's disease: iPSCs towards better understanding of human pathology

S Avazzadeh, JM Baena, C Keighron… - Brain Sciences, 2021 - mdpi.com
Parkinson's Disease (PD) is a chronic neurodegenerative disorder characterized by motor
and non-motor symptoms, among which are bradykinesia, rigidity, tremor as well as mental …

[PDF][PDF] In vivo, in vitro and pharmacologic models of Parkinson's disease.

S Salari, M Bagheri - Physiological research, 2019 - academia.edu
Summary Parkinson's disease (PD), which is the second most common neurodegenerative
disorder after Alzheimer's disease, is firstly defined after James Parkinson's report. It carries …

PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons

H Bogetofte, P Jensen, M Ryding, SI Schmidt… - Frontiers in cellular …, 2019 - frontiersin.org
The protein parkin, encoded by the PARK2 gene, is vital for mitochondrial homeostasis, and
although it has been implicated in Parkinson's disease (PD), the disease mechanisms …

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders

KA Jellinger - Journal of Neural Transmission, 2019 - Springer
Extrapyramidal movement disorders include hypokinetic rigid and hyperkinetic or mixed
forms, most of them originating from dysfunction of the basal ganglia (BG) and their …

The role of KATP channel blockade and activation in the protection against neurodegeneration in the rotenone model of Parkinson's disease

NF Abdelkader, HA Farid, ER Youness… - Life Sciences, 2020 - Elsevier
Aims Several studies suggested that ATP-sensitive potassium channels (K ATP) are
potential therapeutic targets for protection against various neurodegenerative disorders, yet …

Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: correlation between Nrf2 and HMGB1/TLR4/PI3K/Akt/mTOR …

RM El-Sayed, AM Abdelaziz, HF Zaki… - International …, 2023 - Elsevier
Neuroinflammation induced by activation of the high mobility group box 1/toll-like receptor 4
(HMGB1/TLR4) axis is one of the principal mechanisms involved in dopaminergic neuronal …

Biological implications of differential expression of mitochondrial-shaping proteins in Parkinson's disease

S Rocha, A Freitas, SC Guimaraes, R Vitorino, M Aroso… - Antioxidants, 2017 - mdpi.com
It has long been accepted that mitochondrial function and morphology is affected in
Parkinson's disease, and that mitochondrial function can be directly related to its …

[HTML][HTML] Proteomic profile of susceptible and multidrug-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae using label-free and immunoproteomic …

S Magalhães, M Aroso, I Roxo, S Ferreira… - Research in …, 2017 - Elsevier
Infectious diseases caused by multidrug-resistant (MDR) Enterobacteriaceae have
exponentially increased in the past decade, and are a major concern in hospitals. In the first …

Neurotoxic Mechanism and Shortcomings of MPTP, 6-OHDA, Rotenone and Paraquat-induced Parkinson's Disease Animal Models

SK Okyere, C Zeng, D Yue, Y Hu - Venoms and Toxins, 2021 - benthamdirect.com
Parkinson's disease (PD) has caused most economies to lose their active human capital.
Due to poor understanding of the pathophysiology of PD, PD animal models were …

[HTML][HTML] Advancements and Challenges in Preclinical Study Models of Neurodegenerative Brain Diseases: Alzheimer's and Parkinson's Diseases

S Salari, M Bagheri - The Neuroscience Journal of Shefaye …, 2024 - shefayekhatam.ir
Introduction: Neurodegenerative diseases such as Alzheimer's and Parkinson's are among
the most common neurological disorders in older adults, characterized by the gradual loss of …